Comparisons of Guideline-Recommended Therapies in Patients With Documented Coronary Artery Disease Having Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy Only (from the REACH International Registry)

American Journal of Cardiology

Volumn 99, Issue 9, 2007, Pages 1212-1215

  Steinberg, Benjamin A ^a   Steg, P Gabriel ^b   Bhatt, Deepak L ^c   Fonarow, Gregg C ^d   Zeymer, Uwe ^e   Cannon, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BICHAT HOSPITAL   (France)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

ANGINA PECTORIS; ARTICLE; CARDIAC PATIENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EVIDENCE BASED PRACTICE; GROUPS BY AGE; HUMAN; OUTPATIENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; REVASCULARIZATION; TREATMENT OUTCOME; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; REGISTRIES; RETREATMENT;

EID: 34247486136     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.039     Document Type: Article

References (13)

1. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
2. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 suppl (2004) e82-e292
3. Ohman E.M., Bhatt D.L., Steg P.G., Goto S., Hirsch A.T., Liau C.S., Mas J.L., Richard A.J., Rother J., and Wilson P.W. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 151 suppl (2006) e1-e10
4. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., Goto S., Liau C.S., Richard A.J., Rother J., and Wilson P.W. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006) 180-189
5. Smith Jr. S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 47 (2006) 2130-2139
6. Danchin N., Grenier O., Ferrieres J., Cantet C., and Cambou J.P. Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey. Heart 88 (2002) 159-162
7. Steg P.G., Iung B., Feldman L.J., Cokkinos D., Deckers J., Fox K.A., Keil U., and Maggioni A.P. Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart 88 (2002) 20-24
8. Kulkarni S.P., Alexander K.P., Lytle B., Heiss G., and Peterson E.D. Long-term adherence with cardiovascular drug regimens. Am Heart J 151 (2006) 185-191
9. Mehilli J., Kastrati A., Dirschinger J., Pache J., Seyfarth M., Blasini R., Hall D., Neumann F.J., and Schomig A. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 287 (2002) 210-215
10. Mueller C., Neumann F.J., Roskamm H., Buser P., Hodgson J.M., Perruchoud A.P., and Buettner H.J. Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention: a prospective study in 1,450 consecutive patients. J Am Coll Cardiol 40 (2002) 245-250
11. Glaser R., Herrmann H.C., Murphy S.A., Demopoulos L.A., DiBattiste P.M., Cannon C.P., and Braunwald E. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 288 (2002) 3124-3129
12. Mosca L., Manson J.E., Sutherland S.E., Langer R.D., Manolio T., Barrett-Connor E., and Writing Group. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 96 (1997) 2468-2482
13. Eagle K.A., Goodman S.G., Avezum A., Budaj A., Sullivan C.M., and Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 359 (2002) 373-377